Akeso Reports 2026 Growth, Advances Global Drug Pipeline
HONG KONG, Aug 27, 2026 Akeso, Inc. announced its 2026 interim results, reporting record commercial drug sales while advancing...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
HONG KONG, Aug 27, 2026 Akeso, Inc. announced its 2026 interim results, reporting record commercial drug sales while advancing...
BOTHELL, Wash., July 8, 2026 Immunome, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...
BOSTON and MORRISTOWN, N.J., July 7, 2026 Biocytogen and Whitehawk Therapeutics have announced a global strategic collaboration to accelerate...
SAN FRANCISCO and SUZHOU, China, June 4, 2026 Innovent Biologics has announced a major breakthrough in precision oncology as...
SOUTH SAN FRANCISCO, California, USA, June 3, 2026 CytomX Therapeutics has announced a significant expansion of its strategic research...
ZURICH, Switzerland – February 27, 2026 Veraxa Biotech AG announced that its shareholders have approved the previously disclosed business...
SPRING HOUSE, Pa., Feb. 4, 2026 — Clinical-stage biotechnology company Third Arc Bio announced the closing of a $52...
PALO ALTO, Calif., Feb. 4, 2026 —Kodiak Sciences Inc. announced that final end-of-study Phase 1b APEX clinical results evaluating...
